Publication Update – DR5 Targeted Nanoparticle Therapy for Cancer

The Future Medicines Institute is pleased to highlight a new publication in ACS Biomacromolecules:

“Antitumor Activity of Death Receptor 5-Targeted Camptothecin-Loaded Nanoparticles in Murine Syngeneic Models.”

Congratulations to all our collaborators and team members who were involved in this work, in particular FMI Senior Research Fellow Michelle Greene.

Please get in touch for any queries regarding this study or if you’re interested in discussing targeted drug-delivery nanotechnologies with our team.

Read the paper here https://lnkd.in/e3kmBNuj

Boland, Anna J., Greene, Michelle K., et al. "Antitumor Activity of Death Receptor 5-Targeted Camptothecin-Loaded Nanoparticles in Murine Syngeneic Models." Biomacromolecules (2025).